Monocyte and granulocyte defect in chronic lymphocytic leukemia

Area of Science:

• Hematology
• Biochemistry
• Oncology

Background:

• Chronic lymphocytic leukemia (CLL) is a hematological malignancy characterized by the accumulation of abnormal lymphocytes.
• Understanding the underlying cellular and enzymatic abnormalities in CLL is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the enzymatic profiles of different leukocyte populations in patients with chronic lymphocytic leukemia (CLL).
• To compare enzyme levels in CLL patients with healthy individuals and with CLL patients in remission.

Main Methods:

• Isolation of enzymatically homogeneous populations of lymphocytes, monocytes, and neutrophils using zonal centrifugation.
• Quantitative analysis of six leukocytic enzymes in isolated cells from untreated CLL patients, in-remission CLL patients, and normal subjects.

Main Results:

• CLL monocytes exhibited deficiencies in beta-glucuronidase, myeloperoxidase, and lysozyme compared to normal controls.
• CLL neutrophils showed severe deficiencies in lysozyme and myeloperoxidase in some cases.
• CLL lymphocytes shared beta-glucuronidase deficiency with monocytes.
• Leukocyte enzyme levels normalized in CLL patients who achieved full remission.
• CLL lymphocytes from untreated patients were unresponsive to mitogens but responsive in remission; monocytes transformed into macrophages.

Conclusions:

• The shared enzyme deficiencies among lymphocytes, monocytes, and neutrophils in CLL suggest an enzymatically interlinked differentiation process.
• Aberrant differentiation of leukemic cells may underlie the observed enzyme deficiencies in CLL.
• Normalization of enzyme levels in remission indicates a potential link between differentiation and disease status.